Finance

Lists
PAR:ASX
Paradigm Biopharmaceuticals Ltd
A$0.24
-2.00%
(-0.0050) 1D
Sep 18, 4:10:25 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for PAR...
Open
A$0.26
High
A$0.26
Low
A$0.24
Mkt. cap
153.33M
Avg. vol.
3.08M
Volume
3.14M
52-wk high
A$0.47
52-wk low
A$0.14
EPS
-A$0.10
Shares outstanding
625.83M
Open
A$0.26
High
A$0.26
Low
A$0.24
Mkt. cap
153.33M
Avg. vol.
3.08M
Volume
3.14M
52-wk high
A$0.47
52-wk low
A$0.14
EPS
-A$0.10
Shares outstanding
625.83M
About Paradigm Biopharmaceuticals Ltd
CEOMarco Polizzi
Employees-
Founded2014
Headquarters-
SectorBiotechnology
Websiteparadigmbiopharma.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
12.58K
12.58K
-12.58K
-12.58K
Cost of goods sold
2.25K
2.25K
3.81K
3.81K
Cost of revenue
2.25K
2.25K
3.81K
3.81K
Research and development expenses
9.51M
9.51M
17.45M
17.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.41M
1.41M
2.22M
2.22M
Operating expense
10.92M
10.92M
19.67M
19.67M
Total operating expenses
10.93M
10.93M
19.67M
19.67M
Operating income
-10.91M
-10.91M
-19.68M
-19.68M
Other non operating income
-188.82K
-188.82K
4.10M
4.10M
EBT including unusual items
-11.62M
-11.62M
-16.54M
-16.54M
EBT excluding unusual items
-11.62M
-11.62M
-16.55M
-16.55M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11.62M
-11.62M
-16.54M
-16.54M
Net profit margin
-92,423.02%
-92,423.02%
131,558.08%
131,558.08%
Earnings per share
-
-
-
-
Interest and investment income
129.45K
129.45K
80.11K
80.11K
Interest expense
-656.28K
-656.28K
-574.16K
-574.16K
Net interest expenses
-526.83K
-526.83K
-494.04K
-494.04K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.88M
-10.88M
-19.64M
-19.64M
Gain or loss from assets sale
5.38K
5.38K
-2.62K
-2.62K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps